血管性認知症の世界市場レポート 2025年

血管性認知症市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.8％で51億1,000万米ドルに成長します。予測期間中に予想される成長の原動力は、血管性認知症に対する意識の高まり、ヘルスケア投資の増加、高齢化、心血管疾患の罹患率の上昇、高血圧の有病率の増加です。予測期間における主な動向としては、技術の進歩、個別化ケアプラン、遠隔医療、遺伝子治療、人工知能の統合などが挙げられます。

心血管疾患の有病率の増加は、血管性認知症市場の成長を促進すると予想されます。心血管疾患には、冠動脈疾患、心不全、不整脈、高血圧などの状態を含む、心臓や血管に影響を及ぼすさまざまな障害が含まれます。不健康なライフスタイル、食生活の乱れ、運動不足、ストレスレベルの上昇、人口の高齢化、肥満、糖尿病、高血圧などの危険因子の増加などの要因が、心血管疾患の増加に寄与しています。これらの疾患は、脳への血流を阻害することで血管性認知症のリスクを高め、酸素や栄養素の不足による認知機能の低下や脳細胞の損傷を引き起こす可能性があります。例えば、2024年9月の英国心臓財団によると、英国では約760万人が心臓・循環器系疾患に罹患しており、男性約400万人、女性約360万人がこれらの疾患を抱えています。これらの病気は、英国における全死亡の27％を占め、年間合計17万人以上、1日当たり約480人が死亡しています。その結果、心血管疾患の有病率の増加が血管性認知症市場の成長を牽引しています。

血管性認知症市場の各社は、競争力を維持するために、マルチモーダル療法などの新しい治療法の開発に注力しています。マルチモーダル療法は、薬物療法、理学療法、心理学的介入など、さまざまな治療アプローチを組み合わせて包括的な治療を提供するものです。例えば、2023年1月、シンガポールを拠点とするバイオ医薬品会社モリアックは、治療法の選択肢が少ない血管性認知症（VaD）に特化したエビデンスに基づく治療薬CognivAiDを発売しました。この製品は、イチョウ、高麗人参、サフランの活性エキスを配合したもので、VaD患者の認知機能低下を遅らせることが示されています。CognivAiDのマルチモーダルな作用は、血管保護、血管調節、神経炎症といった血管性認知症の主要メカニズムに対応しています。CognivAiDは、広範な臨床試験と強力な安全性プロファイルに裏打ちされた、VaD患者に対する有望な新しい治療法です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血管性認知症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の血管性認知症市場：成長率分析
• 世界の血管性認知症市場の実績：規模と成長, 2019-2024
• 世界の血管性認知症市場の予測：規模と成長, 2024-2029, 2034F
• 世界血管性認知症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血管性認知症市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 小分子
• ペプチド
• 世界の血管性認知症市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の血管性認知症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• リハビリテーションセンター
• 専門クリニック
• 世界の血管性認知症市場モノクローナル抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗アミロイドモノクローナル抗体
• 抗タウモノクローナル抗体
• 世界の血管性認知症市場、小分子のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コリンエステラーゼ阻害剤
• グルタミン酸モジュレーター
• 抗炎症性小分子
• 世界の血管性認知症市場ペプチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミロイドβ標的ペプチド
• 神経保護ペプチド
• タウ標的ペプチド

第7章 地域別・国別分析

• 世界の血管性認知症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血管性認知症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血管性認知症市場：競合情勢
• 血管性認知症市場：企業プロファイル
  • Intermountain Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CSPC Ouyi Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Duke Health Overview, Products and Services, Strategy and Financial Analysis
  • Massachusetts General Hospital Overview, Products and Services, Strategy and Financial Analysis
  • Emory Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Apollo Hospitals Enterprise Limited
• Amedisys Inc.
• Northwestern Memorial HealthCare
• IBS Hospitals Pvt. Ltd.
• Resverlogix Corp.
• ProNeurogen Inc.
• Cyclerion Therapeutics Inc.
• Aribio Inc.
• Pinteon Therapeutics Inc.
• Dementech Neurosciences Ltd.
• Moleac Pte. Ltd.
• Isaac Health Inc.
• Cadabam's Group of Hospitals
• Alpha Cognition Inc.
• Citi Health

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血管性認知症市場2029：新たな機会を提供する国
• 血管性認知症市場2029：新たな機会を提供するセグメント
• 血管性認知症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vascular dementia is a form of cognitive decline caused by reduced blood flow to the brain, often resulting from strokes or other vascular issues. This condition leads to memory loss and impaired thinking. Treatment for vascular dementia primarily focuses on managing underlying vascular conditions, such as controlling high blood pressure, diabetes, and cholesterol, along with promoting a healthy lifestyle to enhance brain health and slow the disease's progression.

Key products in the treatment of vascular dementia include monoclonal antibodies, small molecules, and peptides. Monoclonal antibodies are designed to target specific proteins or molecules related to the disease. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and are intended for use in hospitals, clinics, rehabilitation centers, and specialty clinics.

The vascular dementia market research report is one of a series of new reports from The Business Research Company that provides vascular dementia market statistics, including vascular dementia industry global market size, regional shares, competitors with a vascular dementia market share, detailed vascular dementia market segments, market trends and opportunities, and any further data you may need to thrive in the vascular dementia industry. This vascular dementia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular dementia market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth during the historical period can be attributed to higher healthcare spending, an increase in the number of patients diagnosed with vascular dementia, a rise in healthcare professionals, the expansion of public health initiatives, and a growing prevalence of diabetes.

The vascular dementia market size is expected to see rapid growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The expected growth in the forecast period is driven by a greater awareness of vascular dementia, rising healthcare investments, an aging population, a higher incidence of cardiovascular diseases, and an increase in the prevalence of high blood pressure. Key trends in the forecast period include technological advancements, personalized care plans, telemedicine, gene therapy, and the integration of artificial intelligence.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular dementia market. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension. Factors such as unhealthy lifestyles, poor dietary habits, physical inactivity, heightened stress levels, aging populations, and an increase in risk factors such as obesity, diabetes, and hypertension are contributing to the rise in cardiovascular diseases. These conditions increase the risk of vascular dementia by disrupting blood flow to the brain, which can lead to cognitive decline and brain cell damage due to insufficient oxygen and nutrients. For example, according to the British Heart Foundation in September 2024, approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women living with these conditions. These diseases are responsible for 27% of all deaths in the UK, totaling over 170,000 deaths annually, or about 480 deaths per day. As a result, the increasing prevalence of cardiovascular diseases is driving the growth of the vascular dementia market.

Companies in the vascular dementia market are focusing on developing new therapies, such as multimodal therapies, to maintain their competitive edge. Multimodal therapies combine various treatment approaches, including medications, physical therapy, and psychological interventions, to provide comprehensive treatment. For example, in January 2023, Moleac, a biopharmaceutical company based in Singapore, launched CognivAiD, an evidence-based treatment specifically designed for vascular dementia (VaD), a condition with few therapeutic options. This product combines active extracts from ginkgo, ginseng, and saffron, which have been shown to slow cognitive decline in VaD patients. The multimodal action of CognivAiD addresses key mechanisms of vascular dementia, such as vascular protection, vasoregulation, and neuroinflammation. Supported by extensive clinical trials and a strong safety profile, CognivAiD offers a promising new treatment for individuals with VaD.

In November 2023, Merck, a US-based pharmaceutical company, acquired Caraway Therapeutics, Inc. for an undisclosed amount. This acquisition is intended to accelerate the development of small-molecule therapeutics targeting neurodegenerative diseases, including Parkinson's disease and dementia. Caraway Therapeutics Inc. is a biopharmaceutical company based in the US, specializing in drug discovery and development for dementia.

Major players in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam's Group of Hospitals, Alpha Cognition Inc., and Citi Health.

North America was the largest region in the vascular dementia market in 2024. The regions covered in vascular dementia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vascular dementia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular dementia market consists of revenues earned by entities providing services such as diagnosis, treatment, care management, and support for individuals. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular dementia market includes sales of assistive devices, cognitive enhancers, and diagnostic tools. Values in this market are 'factory gate' values, meaning the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including healthcare providers, wholesalers, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Dementia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular dementia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular dementia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular dementia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Monoclonal Antibodies; Small Molecules; Peptides
• 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 3) By End User: Hospitals And Clinics; Rehabilitation Centers; Specialty Clinics
• Subsegments:
• 1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies; Anti-Tau Monoclonal Antibodies
• 2) By Small Molecules: Cholinesterase Inhibitors; Glutamate Modulators; Anti-Inflammatory Small Molecules
• 3) By Peptides: Amyloid-Beta Targeted Peptides; Neuroprotective Peptides; Tau-Targeting Peptides
• Companies Mentioned: Intermountain Healthcare Inc.; CSPC Ouyi Pharmaceutical Co. Ltd.; Duke Health; Massachusetts General Hospital; Emory Healthcare Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Dementia Market Characteristics

3. Vascular Dementia Market Trends And Strategies

4. Vascular Dementia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vascular Dementia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vascular Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vascular Dementia Market Growth Rate Analysis
• 5.4. Global Vascular Dementia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vascular Dementia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vascular Dementia Total Addressable Market (TAM)

6. Vascular Dementia Market Segmentation

• 6.1. Global Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Small Molecules
• Peptides
• 6.2. Global Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.3. Global Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Rehabilitation Centres
• Speciality Clinics
• 6.4. Global Vascular Dementia Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Amyloid Monoclonal Antibodies
• Anti-Tau Monoclonal Antibodies
• 6.5. Global Vascular Dementia Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cholinesterase Inhibitors
• Glutamate Modulators
• Anti-Inflammatory Small Molecules
• 6.6. Global Vascular Dementia Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amyloid-Beta Targeted Peptides
• Neuroprotective Peptides
• Tau-Targeting Peptides

7. Vascular Dementia Market Regional And Country Analysis

• 7.1. Global Vascular Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vascular Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vascular Dementia Market

• 8.1. Asia-Pacific Vascular Dementia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vascular Dementia Market

• 9.1. China Vascular Dementia Market Overview
• 9.2. China Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vascular Dementia Market

• 10.1. India Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vascular Dementia Market

• 11.1. Japan Vascular Dementia Market Overview
• 11.2. Japan Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vascular Dementia Market

• 12.1. Australia Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vascular Dementia Market

• 13.1. Indonesia Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vascular Dementia Market

• 14.1. South Korea Vascular Dementia Market Overview
• 14.2. South Korea Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vascular Dementia Market

• 15.1. Western Europe Vascular Dementia Market Overview
• 15.2. Western Europe Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vascular Dementia Market

• 16.1. UK Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vascular Dementia Market

• 17.1. Germany Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vascular Dementia Market

• 18.1. France Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vascular Dementia Market

• 19.1. Italy Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vascular Dementia Market

• 20.1. Spain Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vascular Dementia Market

• 21.1. Eastern Europe Vascular Dementia Market Overview
• 21.2. Eastern Europe Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vascular Dementia Market

• 22.1. Russia Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vascular Dementia Market

• 23.1. North America Vascular Dementia Market Overview
• 23.2. North America Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vascular Dementia Market

• 24.1. USA Vascular Dementia Market Overview
• 24.2. USA Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vascular Dementia Market

• 25.1. Canada Vascular Dementia Market Overview
• 25.2. Canada Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vascular Dementia Market

• 26.1. South America Vascular Dementia Market Overview
• 26.2. South America Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vascular Dementia Market

• 27.1. Brazil Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vascular Dementia Market

• 28.1. Middle East Vascular Dementia Market Overview
• 28.2. Middle East Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vascular Dementia Market

• 29.1. Africa Vascular Dementia Market Overview
• 29.2. Africa Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vascular Dementia Market Competitive Landscape And Company Profiles

• 30.1. Vascular Dementia Market Competitive Landscape
• 30.2. Vascular Dementia Market Company Profiles
  • 30.2.1. Intermountain Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. CSPC Ouyi Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Duke Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Massachusetts General Hospital Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Emory Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Vascular Dementia Market Other Major And Innovative Companies

• 31.1. Apollo Hospitals Enterprise Limited
• 31.2. Amedisys Inc.
• 31.3. Northwestern Memorial HealthCare
• 31.4. IBS Hospitals Pvt. Ltd.
• 31.5. Resverlogix Corp.
• 31.6. ProNeurogen Inc.
• 31.7. Cyclerion Therapeutics Inc.
• 31.8. Aribio Inc.
• 31.9. Pinteon Therapeutics Inc.
• 31.10. Dementech Neurosciences Ltd.
• 31.11. Moleac Pte. Ltd.
• 31.12. Isaac Health Inc.
• 31.13. Cadabam's Group of Hospitals
• 31.14. Alpha Cognition Inc.
• 31.15. Citi Health

32. Global Vascular Dementia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Dementia Market

34. Recent Developments In The Vascular Dementia Market

35. Vascular Dementia Market High Potential Countries, Segments and Strategies

• 35.1 Vascular Dementia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vascular Dementia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vascular Dementia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer